Mentorship Program in Classical Hematology Facilitates Career Development
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- A mentorship pilot program in classical hematology can facilitate career development and improve retention in the field, according to a study published online Aug. 1 in Blood Advances.
Noting that there is a lack of mentorship opportunities within classical hematology versus medical oncology, Zoya Qureshy, M.D., from the University of California San Diego in La Jolla, and colleagues developed a year-long external mentorship program implemented through the American Society of Hematology Medical Educators Institute. Thirty-five hematology/oncology fellows interested in classical hematology were paired in a meticulous process with 34 academically productive faculty mentors from different institutions across North America. Pairs were expected to meet once a month virtually and could participate in a scholarly project. The program was assessed using mentee and mentor surveys, a mentee interview, and a mentee focus group.
The researchers found that 33 of the pairs completed the program (94.2 percent). Of the mentee respondents, 63 percent worked on a scholarly project with their mentor, and several mentees received publications, grants, and awards. Perception by the mentee that their mentor was a good match was associated with a perceived positive impact on confidence, career development, and professional identity. After fellowship, 23 mentees (66 percent) accepted classical hematology faculty positions. All mentors believed that the program would improve retention in classical hematology.
"This study shows that effective, deliberate mentorship is vital for career advancement, especially for trainees," Qureshy said in a statement. "Virtual communication can foster strong external mentorships and relationships for those who might not have as much institutional, local mentorship readily available."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-06 07:15
Read more
- Nationwide, Couple-Based Reproductive Carrier Screening Program Demonstrates Feasbility
- Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder
- Dose-Dependent Association Seen for Smoking, CVD Risk
- Improvement Seen in Some Features of PCOS With Weight Loss Interventions
- Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
- American College of Gastroenterology, Oct. 25-30
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions